Journal Article (360)
301.
Journal Article
91 (7), pp. 1754 - 1763 (2010)
High yields of Influenza A virus in MDCK cells are promoted by an insufficient IFN-induced antiviral state. Journal of General Virology 302.
Journal Article
168 (1-2), pp. 63 - 71 (2010)
Real-time RT-qPCR assay for the analysis of human influenza A virus transcription and replication dynamics. Journal of Virological Methods 303.
Journal Article
73 (9), pp. 1656 - 1669 (2010)
Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: A proteomic approach. Journal of Proteomics 304.
Journal Article
107 (2), pp. 312 - 320 (2010)
Purification of cell culture-derived modified Vaccinia Ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography. Biotechnology and Bioengineering 305.
Journal Article
105 (4), pp. 761 - 769 (2010)
Capturing of Cell Culture-Derived Modified Vaccinia Ankara Virus by Ion Exchange and Pseudo-Affinity Membrane Adsorbers. Biotechnology and Bioengineering 306.
Journal Article
25 (6), pp. 1717 - 1731 (2009)
Growth behaviour of number distributed adherent MDCK cells for optimization in large scale microcarrier cultures. Biotechnology Progress 307.
Journal Article
8 (12), pp. 1681 - 1692 (2009)
Continuous cell lines as production system for influenza vaccines. Expert Review of Vaccines 308.
Journal Article
27 (36), pp. 4975 - 4982 (2009)
New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation. Vaccine 309.
Journal Article
161 (2), pp. 312 - 316 (2009)
Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography. Journal of Virological Methods 310.
Journal Article
103 (6), pp. 1144 - 1154 (2009)
Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles. Biotechnology and Bioengineering 311.
Journal Article
81 (1), pp. 443 - 452 (2009)
Atmospheric Pressure Free Liquid Infrared MALDI Mass Spectrometry: Toward a combined ESI/MALDI-Liquid Chromatography Interface. Analytical Chemistry 312.
Journal Article
27 (20), pp. 2712 - 2722 (2009)
Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production – flow cytometry and mathematical modeling. Vaccine 313.
Journal Article
27 (32), pp. 4325 - 4336 (2009)
Glycan analysis in cell culture-based influenza vaccine production: Influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. Vaccine 314.
Journal Article
9 (12), pp. 3316 - 3327 (2009)
Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines. Proteomics 315.
Journal Article
30 (3), pp. 415 - 420 (2008)
Profiling of external metabolites during production of hantavirus nucleocapsid protein with recombinant Saccharomyces cerevisiae. Biotechnology Letters 316.
Journal Article
873 (1), pp. 102 - 112 (2008)
Size-exclusion chromatography as a linear transfer system: Purification of human influenza virus as an example. Journal of Chromatography B 317.
Journal Article
36 (3), pp. 145 - 161 (2008)
Monitoring Influenza Virus Content in Vaccine Production: Precise Assays for the Quantitation of Hemagglutination and Neuraminidase Activity. Biologicals 318.
Journal Article
24 (1), pp. 110 - 119 (2008)
Segregated Mathematical Model for Growth of Anchorage-Dependent MDCK Cells in Microcarrier Culture. Biotechnology Progress 319.
Journal Article
154 (1-2), pp. 61 - 68 (2008)
Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent. Journal of Virological Methods 320.
Journal Article
80 (6), pp. 821 - 830 (2008)
Auslegungsunterlagen für Bioreaktoren zur Maßstabsvergrößerung eines microcarrierbasierenden Virusproduktionsprozesses. Chemie-Ingenieur-Technik 321.
Journal Article
373, pp. 349 - 369 (2008)
Simultaneous extraction of several metabolites of energy metabolism and related substances in mammalian cells: Optimization using experimental design. Analytical Biochemistry 322.
Journal Article
8, 45 (2008)
Flow cytometric monitoring of influenza A virus infection in MDCK cells during vaccine production. BMC Biotechnology 323.
Journal Article
29 (20), pp. 4203 - 4214 (2008)
N-Glycan Analysis by CGE-LIF – Profiling Influenza A Virus Hemagglutinin N-Glycosylation during Vaccine Production. Electrophoresis 324.
Journal Article
8 (4), pp. 399 - 414 (2008)
Mathematical model of growth and heterologous hantavirus protein production of the recombinant yeast Saccharomyces cerevisiae. Engineering in Life Sciences 325.
Journal Article
63, pp. 157 - 169 (2008)
Stochastic Population Balance Modeling of Influenza Virus Replication in Vaccine Production Processes. Chemical Engineering Science 326.
Journal Article
63 (8), pp. 2299 - 2304 (2008)
Stochastic population balance modeling of influenza virus replication in vaccine production processes. II. Detailed description of the replication mechanism. Chemical Engineering Science 327.
Journal Article
24 (2), pp. 311 - 320 (2008)
Comparison of Metabolic Flux Distributions for MDCK Cell Growth in Glutamine- and Pyruvate-Containing Media. Biotechnology Progress 328.
Journal Article
101 (1), pp. 135 - 152 (2008)
Metabolic flux model for an anchorage-dependent MDCK cell line: Characteristic Growth Phases and Minimum Substrate Consumption Flux Distribution. Biotechnology and Bioengineering 329.
Journal Article
9, 152 (2008)
13C labeling experiments at metabolic nonstationary conditions: an exploratory study. BMC Bioinformatics 330.
Journal Article
31 (6), pp. 846 - 857 (2008)
Downstream Processing: From egg to cell culture-derived influenza virus particles. Chemical Engineering and Technology 331.
Journal Article
46 (13), pp. 4686 - 4694 (2007)
Hydrodynamic characteristics and expansion behavior of beds containing single and binary-mixtures of particles. Industrial and Engineering Chemistry Research 332.
Journal Article
25 (20), pp. 3987 - 3995 (2007)
Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale. Vaccine 333.
Journal Article
97 (1), pp. 73 - 85 (2007)
Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotechnology and Bioengineering 334.
Journal Article
299, pp. 251 - 260 (2007)
Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers. Journal of Membrane Science 335.
Journal Article
96, pp. 932 - 944 (2007)
Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnology and Bioengineering 336.
Journal Article
23 (18), pp. 9271 - 9281 (2007)
Concentration Polarization and Nonequilibrium Electroosmotic Slip in Dense Multiparticle Systems. Langmuir 337.
Journal Article
5, p. 46 (2007)
Visualizing Regulatory Interactions in Metabolic Networks. BMC Biology 338.
Journal Article
131 (3), pp. 309 - 317 (2007)
Impact of adsorbents selection on affinity purification efficiency of cell culture derived human Influenza viruses. Journal of Biotechnology 339.
Journal Article
25 (5), pp. 939 - 947 (2007)
Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses. Vaccine 340.
Journal Article
26 (12), pp. 1552 - 1565 (2007)
Development and optimisation of a procedure for the production of Parapoxvirus Ovis by large scale microcarrier cell culture in a non animal, non human and non plant derived medium. Vaccine 341.
Journal Article
124 (2), pp. 347 - 362 (2006)
Production of hantavirus Puumala nucleocapsid protein in Saccharomyces cerevisiae for vaccine and diagnostics. Journal of Biotechnology 342.
Journal Article
24, pp. 3261 - 3272 (2006)
Serum-free influenza virus production avoiding washing steps & medium exchange in large-scale microcarrier culture. Vaccine 343.
Journal Article
24 (35-36), pp. 6074 - 6087 (2006)
Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Vaccine 344.
Journal Article
53 (4), pp. 556 - 584 (2006)
Coexistence in the Chemostat as a result of metabolic by-products. Journal of mathematical biology 345.
Journal Article
10 (4), pp. 18 - 20 (2006)
Preparative Size-Exclusion Chromatography. GIT Laboratory Journal Europe 346.
Journal Article
843 (2), pp. 216 - 226 (2006)
High-performance anion-exchange chromatography using on-line electrolytic eluent generation for the determination of more than 25 intermediates from energy metabolism of mammalian cells in culture. Journal of Chromatography B 347.
Journal Article
96 (4), pp. 738 - 756 (2006)
Characterization of a Three Bacteria Mixed Culture in a Chemostat: Evaluation and Application of a Quantitative Terminal-Restriction Fragment Polymorphism (T-RFLP) Analysis for Absolute and Species Specific Cell Enumeration. Biotechnology and Bioengineering 348.
Journal Article
21 (1), pp. 58 - 69 (2005)
Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells. Biotechnology Progress 349.
Journal Article
90 (1), pp. 46 - 58 (2005)
Mathematical Model of Influenza A Virus Production in Large-Scale Microcarrier Culture. Biotechnology and Bioengineering 350.
Journal Article
823 (2), pp. 75 - 81 (2005)
Downstream processing of MDCK cell-derived equine influenza virus. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences